| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |